[Stimulated angiogenesis: a new trend in the treatment of ischemic conditions].
Davydenko
V V
VV
Machs
V M
VM
D000368:Aged; D043925:Angiogenesis Inducing Agents / Q000627:therapeutic use*; D000818:Animals; D017209:Apoptosis; D001157:Arterial Occlusive Diseases / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D003097:Collateral Circulation; D001026:Coronary Artery Bypass; D003326:Coronary Circulation; D004285:Dogs; D016228:Endothelial Growth Factors / Q000235:genetics; D005260:Female; D005346:Fibroblast Growth Factors / Q000627:therapeutic use*; D018014:Gene Transfer Techniques; D006801:Humans; D007511:Ischemia / Q000188:drug therapy*; D007866:Leg / Q000098:blood supply*; D008222:Lymphokines / Q000235:genetics; D008297:Male; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000188:drug therapy*; D018919:Neovascularization, Physiologic; D020033:Protein Isoforms; D013002:Somatomedins / Q000627:therapeutic use; D013552:Swine; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D043925:Angiogenesis Inducing Agents; D016228:Endothelial Growth Factors; D008222:Lymphokines; D020033:Protein Isoforms; D013002:Somatomedins; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D005346:Fibroblast Growth Factors